Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported Gross Profit of $463.26 million for fiscal year 2025.
COLLEGIUM PHARMACEUTICAL, INC Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $463.26M | +22.8% |
| 2024 | $377.34M | +15.7% |
| 2023 | $326.17M | +55.7% |
| 2022 | $209.49M | +39.1% |
| 2021 | $150.62M | -16.2% |
| 2020 | $179.84M | +74.5% |
| 2019 | $103.04M | -10.2% |
| 2018 | $114.74M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $129.17M | +33.4% | +19.2% |
| June 30, 2025 | $108.38M | +19.4% | +11.4% |
| March 31, 2025 | $97.32M | +6.4% | +0.5% |
| September 30, 2024 | $96.79M | +20.5% | +6.6% |
| June 30, 2024 | $90.81M | +23.0% | -0.7% |
| March 31, 2024 | $91.46M | +18.2% | +13.9% |
| September 30, 2023 | $80.31M | +36.5% | +8.8% |
| June 30, 2023 | $73.83M | +41.0% | -4.6% |
- COLLEGIUM PHARMACEUTICAL, INC showed an increase of +22.8% in Gross Profit compared to the prior fiscal year.
- Over the 2018–2025 period, COLLEGIUM PHARMACEUTICAL, INC’s gross profit has grown by 303.8% (from $114.74 million to $463.26 million).
- The most recent figure is from COLLEGIUM PHARMACEUTICAL, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: